NEW YORK (Reuters Health), May 9 - For bowel cleansing before colonoscopy, a new 2-L solution of polyethylene glycol (PEG) plus ascorbic acid is as effective as the standard 4-L PEG plus electrolytes solution and is more acceptable to patients, researchers report in the American Journal of Gastroenterology for April.
The addition of ascorbic acid appears not only to improve the taste of the gut lavage solution, it also reduces the effective volume of solution needed for adequate cleansing, Dr. Christian Ell, from Dr. Horst Schmidt Kliniken, Wiesbaden, Germany, and colleagues explain.
"The cathartic effects of ascorbic acid are thought to be due to its absorption mechanism, which becomes saturated at high doses. Excess ascorbic acid, which cannot be absorbed, remains in the bowel where it exerts an osmotic effect, acting synergistically with PEG," they note.
In a randomized study, Ell and colleagues tested the safety, efficacy, and patient acceptability of the 2-L PEG with ascorbic acid solution (PEG + Asc; Moviprep, Norgine, Harefield, U.K.) with that of the standard 4-L PEG with electrolytes solution (PEG + E; Klean-Prep, Norgine) for bowel cleansing before colonoscopy. Both groups used a split-dose regimen, i.e., taking half of the solution the evening before the colonoscopy and the other half early in the morning of the procedure.
Successful gut cleansing was achieved in 136 of 153 patients (88.9%) who used the 2-L PEG + Asc solution and in 147 of 155 patients (94.8%) who used the 4-L PEG + E solution. The difference fell within the predefined limit for noninferiority, note the researchers.
Patients who drank the 2-L PEG + Asc solution reported significantly less nausea and abdominal pain than those who drank the standard 4-L solution.
"Patients were also asked about the acceptability and taste of the cleansing agent and rated the 2-L PEG + Asc solution significantly better than the 4-L PEG solution on both counts," the investigators report. Therefore, the 2-L solution "may be associated with improved treatment adherence," Ell and colleagues conclude.
Am J Gastroenterol 2008;103:883-893.
Last Updated: 2008-05-09 10:04:23 -0400 (Reuters Health)
Related Reading
Bowel prep with sodium phosphate or PEG pose low risks of renal impairment, January 4, 2008
Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
